Objective:

To raise awareness about the benefits of preservative-free medications for ocular surface health and overall treatment adherence in glaucoma patients.

Key Findings:

• Long-term use of preserved eye drops can cause ocular surface damage and inflammation, as supported by recent studies.
• Preservative-free medications improve patient comfort and reduce side effects such as redness and irritation, leading to better adherence.
• Patients are more likely to adhere to treatment when using preservative-free options, which can enhance overall treatment outcomes.

Interpretation:

The PFC emphasizes the critical role of preservative-free medications in improving the quality of life for glaucoma patients and reducing ocular surface toxicity, while advocating for necessary policy changes.

Limitations:

• Preservative-free medications are often more expensive than preserved alternatives, which can limit patient access.
• Insurance coverage for preservative-free options may be limited, creating barriers for patients seeking these treatments.

Conclusion:

Advocacy for preservative-free glaucoma drops is crucial for enhancing patient safety and treatment adherence, with ongoing efforts needed to address cost and accessibility challenges.